Use of benzimidazole-proline derivatives
US9914721B2 · kind B2 · utility
4Cited by
19References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 3, 2014 |
| Grant date | Mar 13, 2018 |
| Priority date | — |
| Expiry date | Dec 3, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of the formula (I)wherein Ar1 and Ar2 are as described in the description and to their use as pharmaceuticals for the treatment of sundown syndrome. The invention also relates to the preparation of such compounds and of pharmaceutically acceptable salts thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.